← All organizations
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2011Last known activity
Nov 25, 2025
Timeline
No events for the selected filters.
Drugs by trial phase (10 distinct, 5 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 2 (3 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Indications
Studied for
Recent trials (8)
- NCT07173855Sponsor investigatorPhase 4Nov 25, 2025
- NCT07173855Lead sponsorPhase 4Nov 25, 2025
- NCT05022329CollaboratorPhase 2/Phase 3Sep 30, 2021
- NCT03186404CollaboratorPhase 2Jul 1, 2017
- NCT01579578Study directorPhase 2Apr 1, 2012
- NCT01750138Overall official - principal investigatorN/AJun 1, 2011
- NCT01750138Lead sponsorN/AJun 1, 2011
- NCT01750138Reponsible party - principal investigatorN/AJun 1, 2011
Details
- Last known activity
- Nov 25, 2025